SG Americas Securities
BMY.RT

SG Americas Securities’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

SG Americas Securities’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-42,534
Closed -$29K – 3691
2020
Q4 		$29K Hold
42,534
– – ﹤0.01% 3187
2020
Q3 		$96K Hold
42,534
– – ﹤0.01% 2468
2020
Q2 		$152K Sell
42,534
-74,035
-64% -$267K ﹤0.01% 3093
2020
Q1 		$443K Buy
116,569
+73,139
+168% +$241K ﹤0.01% 1935
2019
Q4 		$131K Buy
+43,430
New +$113K ﹤0.01% 2791

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

SG Americas Securities's BMY.RT Position: Q1 2021 in Review

SG Americas Securities sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 42,534 shares — an estimated $29K sold.

SG Americas Securities first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $443K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • SG Americas Securities reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • SG Americas Securities sold 42,534 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $29K.
  • SG Americas Securities first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • SG Americas Securities's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $443K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on SG Americas Securities's 13F filing for Q1 2021, filed 13 May 2021.